Home / Stacks / Ipamorelin + CJC-1295 (No DAC)
Synergistic Longevity Protocol

Ipamorelin + CJC-1295 (No DAC) Stack

Maximized pulsatile GH release with minimal side effects.

Mechanism of Synergy

The gold standard GH stack. CJC-1295 (No DAC) provides the GHRH pulse while Ipamorelin provides the GHRP pulse.

The combination of Ipamorelin and CJC-1295 (No DAC) represents a multi-pathway approach to biological age reduction. By simultaneously targeting distinct hallmarks of aging, this protocol achieves results that exceed the sum of its individual components.

Ipamorelin primarily acts via selective ghrelin receptor (ghsr) agonist that stimulates pulsatile gh release with minimal effect on cortisol or prolactin., while CJC-1295 (No DAC) complements this by short-acting ghrh analog (mod grf 1-29) that stimulates pulsatile gh release mimicking natural physiological rhythms.. Together, they create a comprehensive cellular environment optimized for longevity and resilience.

Targeted Hallmarks of Aging

Ipamorelin Targets

Deregulated Nutrient SensingMitochondrial Dysfunction

CJC-1295 (No DAC) Targets

Systemic effects
Clinical Implementation

Start This Protocol

Alukard provides physician-supervised longevity protocols, including the Ipamorelin + CJC-1295 (No DAC) stack, with GMP-certified compounds and comprehensive biomarker testing.

Get Physician Consultation
Physician-Supervised Longevity

Begin Your Age Reversal Protocol for Ipamorelin + CJC-1295 (No DAC) Stack

Alukard provides physician-supervised longevity protocols with GMP-certified compounds, biomarker testing, and personalized biological age reduction programs.

HIPAA Compliant · GMP Certified · Physician Supervised · Biomarker Testing